Abstract
Myocardial infarction causes a loss of cardiac muscle and therefore an impairment of cardiac function. The surviving cardiac myocytes cannot repair the damage, even if they have a minimal proliferative capacity. Based on these observations, cell therapy for myocardial infarction has developed over the last 15 years, both at the preclinical and clinical levels. Several meta-analyses, covering more than 1000 patients enrolled in small trials (
| Translated title of the contribution | Repairing the heart with new cells |
|---|---|
| Original language | Italian |
| Pages (from-to) | 212-215 |
| Number of pages | 4 |
| Journal | Ricerca e Pratica |
| Volume | 30 |
| Issue number | 5 |
| Publication status | Published - Sep 1 2014 |
ASJC Scopus subject areas
- Medicine(all)